Citations (406)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Tamas Fulop, Charles Ramassamy, Simon Lévesque, Eric H Frost, Benoit Laurent, Guy Lacombe, Abedelouahed Khalil, Anis Larbi, Katsuiku Hirokawa, Mathieu Desroches, Serafim Rodrigues, Karine Bourgade, Alan A Cohen & Jacek M. Witkowski. (2023) Viruses - a major cause of amyloid deposition in the brain. Expert Review of Neurotherapeutics 23:9, pages 775-790.
Read now
Read now
Florian Lasch, Lorenzo Guizzaro, Frank Pétavy & Ciro Gallo. (2023) A Simulation Study on the Estimation of the Effect in the Hypothetical Scenario of No Use of Symptomatic Treatment in Trials for Disease-Modifying Agents for Alzheimer’s Disease. Statistics in Biopharmaceutical Research 15:2, pages 386-399.
Read now
Read now
Shivani Gupta & Ashok Kumar Dasmahapatra. (2023) Destabilization of Aβ fibrils by omega-3 polyunsaturated fatty acids: a molecular dynamics study. Journal of Biomolecular Structure and Dynamics 41:2, pages 581-598.
Read now
Read now
Ryan A. Mace, Jonathan Greenberg, Matthew Stauder, Gretchen Reynolds & Ana-Maria Vranceanu. (2022) My Healthy Brain: a multimodal lifestyle program to promote brain health. Aging & Mental Health 26:5, pages 980-991.
Read now
Read now
Gregory R. Goodwin, Jonathan P. Bestwick & Alastair J. Noyce. (2022) The potential utility of smell testing to screen for neurodegenerative disorders. Expert Review of Molecular Diagnostics 22:2, pages 139-148.
Read now
Read now
Sahar Omidpanah, Yasaman Vahedi-Mazdabadi, Azadeh Manayi, Arezoo Rastegari, Roshanak Hariri, Elahe Mortazavi-Ardestani, Mahdieh Eftekhari, Mahnaz Khanavi, Tahmineh Akbarzadeh & Mina Saeedi. (2022) Phytochemical investigation and anticholinesterase activity of ethyl acetate fraction of Myristica fragrans Houtt. seeds. Natural Product Research 36:2, pages 610-616.
Read now
Read now
Tamas Fulop, Shreyansh Tripathi, Serafim Rodrigues, Mathieu Desroches, Ton Bunt, Arnold Eiser, Francois Bernier, Pascale B Beauregard, Annelise E Barron, Abdelouahed Khalil, Adam Plotka, Katsuiku Hirokawa, Anis Larbi, Christian Bocti, Benoit Laurent, Eric H Frost & Jacek M Witkowski. (2021) Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease. Neuropsychiatric Disease and Treatment 17, pages 1311-1339.
Read now
Read now
Fatima Y. Adeowo, Murtala A. Ejalonibu, Ahmed A. Elrashedy, Monsurat M. Lawal & Hezekiel M. Kumalo. (2021) Multi-target approach for Alzheimer’s disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-N-phenylaminoquinoline derivative reveal promising potentials. Journal of Biomolecular Structure and Dynamics 39:11, pages 3825-3841.
Read now
Read now
Liuqing Yang, Xifeng Wang, Qi Guo, Scott Gladstein, Dustin Wooten, Tengfei Li, Weining Z Robieson, Yan Sun & Xin Huang. (2021) Deep Learning Based Multimodal Progression Modeling for Alzheimer’s Disease. Statistics in Biopharmaceutical Research 13:3, pages 337-343.
Read now
Read now
Marjan Talebi, Eleni Kakouri, Mohsen Talebi, Petros A. Tarantilis, Tahereh Farkhondeh, Selen İlgün, Ali Mohammad Pourbagher-Shahri & Saeed Samarghandian. (2021) Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease. Expert Review of Neurotherapeutics 21:6, pages 625-642.
Read now
Read now
Yiran Wang & Rickie Patani. (2020) Novel therapeutic targets for amyotrophic lateral sclerosis: ribonucleoproteins and cellular autonomy. Expert Opinion on Therapeutic Targets 24:10, pages 971-984.
Read now
Read now
William J. Bosl. (2018) The Emerging Role of Neurodiagnostic Informatics in Integrated Neurological and Mental Health Care. The Neurodiagnostic Journal 58:3, pages 143-153.
Read now
Read now
Kunmeng Liu, Hui-Heng Lin, Rongbiao Pi, Shinghung Mak, Yifan Han & Yuanjia Hu. (2018) Research and development of anti-Alzheimer’s disease drugs: an update from the perspective of technology flows. Expert Opinion on Therapeutic Patents 28:4, pages 341-350.
Read now
Read now
Articles from other publishers (393)
Chengxi Zang, Hao Zhang, Jie Xu, Hansi Zhang, Sajjad Fouladvand, Shreyas Havaldar, Feixiong Cheng, Kun Chen, Yong Chen, Benjamin S. Glicksberg, Jin Chen, Jiang Bian & Fei Wang. (2023) High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data. Nature Communications 14:1.
Crossref
Crossref
Harshitha Santhosh Kumar, James Moore, Adrian C. Steiner, Emmanuel Sotirakis, Benjamin Schärli, Patricia Isnard-Petit, Kader Thiam, David P. Wolfer & Erik C. Böttger. (2023) Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain. Cellular and Molecular Life Sciences 80:12.
Crossref
Crossref
Adem Korkmaz, Lydia Rhyman & Ponnadurai Ramasami. (2023) Synthesis, characterization, DFT and molecular docking studies of acetone O-((2,5-dichlorophenyl)sulfonyl) oxime. Physical Sciences Reviews 8:11, pages 4017-4028.
Crossref
Crossref
Sachin Kammula, Sulagna Tripathi, Ning Wang, Valina L. Dawson, Ted M. Dawson & Xiaobo Mao. (2023) Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease. Ageing and Neurodegenerative Diseases 3:4.
Crossref
Crossref
Chuan Hu, Baoyu Wu, Yihan Wu, Mingyi Shi, Jiaqi Ma, Huile Gao & Jinming Zhang. (2023) Recent advances in nanotechnology for combating Alzheimer's disease. Materials Chemistry Frontiers 7:21, pages 5171-5186.
Crossref
Crossref
Nárlon C. Boa Sorte Silva, Lisanne F. ten Brinke, Allison A. M. Bielak, Todd C. Handy & Teresa Liu-Ambrose. (2023) Improved intraindividual variability in cognitive performance following cognitive and exercise training in older adults. Journal of the International Neuropsychological Society, pages 1-11.
Crossref
Crossref
David A. Loeffler. (2023) Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects. Journal of Alzheimer's Disease Reports 7:1, pages 873-899.
Crossref
Crossref
Joschka Bauer, Nandhini Rajagopal, Priyanka Gupta, Pankaj Gupta, Andrew E. Nixon & Sandeep Kumar. (2023) How can we discover developable antibody-based biotherapeutics?. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Qian Li, Xi Yang, Jie Xu, Yi Guo, Xing He, Hui Hu, Tianchen Lyu, David Marra, Amber Miller, Glenn Smith, Steven DeKosky, Richard D. Boyce, Karen Schliep, Elizabeth Shenkman, Demetrius Maraganore, Yonghui Wu & Jiang Bian. (2023) Early prediction of Alzheimer's disease and related dementias using real‐world electronic health records. Alzheimer's & Dementia 19:8, pages 3506-3518.
Crossref
Crossref
Felix Oluwasegun Ishabiyi, James Okwudirichukwu Ogidi, Baliqis Adejoke Olukade, Chizoba Christabel Amorha, Lina Y. El-Sharkawy, Chukwuemeka Calistus Okolo, Titilope Mary Adeniyi, Nkechi Hope Atasie, Abdulwasiu Ibrahim & Toheeb Adewale Balogun. (2023) Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer’s Disease. Journal of Alzheimer's Disease 94:s1, pages S67-S85.
Crossref
Crossref
Jan Schürmann & Manuel Trachsel. (2023) Ethical Issues of Primary and Secondary Dementia Prevention. GeroPsych.
Crossref
Crossref
Hemant Srivastava, Alexander Tate Lasher, Akash Nagarajan & Liou Y. Sun. (2023)
Sexual dimorphism in the peripheral metabolic homeostasis and behavior in the
TgF344‐AD
rat model of Alzheimer's disease
. Aging Cell 22:7.
Crossref
Crossref
Jennifer Rollo, John Crawford & John Hardy. (2023) A dynamical systems approach for multiscale synthesis of Alzheimer’s pathogenesis. Neuron 111:14, pages 2126-2139.
Crossref
Crossref
Marina Passero, Tianhua Zhai & Zuyi Huang. (2023) Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer’s Disease. International Journal of Environmental Research and Public Health 20:13, pages 6217.
Crossref
Crossref
Matthew C. Findlay, Majid KhanMrinmoy Kundu, Chase M. Johansen & Brandon Lucke-Wold. (2023) Innovative Discoveries in Neurosurgical Treatment of Neurodegenerative
Diseases: A Narrative Review. Current Alzheimer Research 20:6, pages 394-402.
Crossref
Crossref
Paul J Foster, Denize Atan, Anthony Khawaja, Andrew Lotery, Tom MacGillivray, Christopher G Owen, Praveen J Patel, Axel Petzold, Alicja Rudnicka, Zihan Sun, Simon Sheard & Naomi Allen. (2023) Cohort profile: rationale and methods of UK Biobank repeat imaging study eye measures to study dementia. BMJ Open 13:6, pages e069258.
Crossref
Crossref
Luisa Diomede, Elisa R. Zanier, Federico Moro, Gloria Vegliante, Laura Colombo, Luca Russo, Alfredo Cagnotto, Carmina Natale, Federica Marta Xodo, Ada De Luigi, Michele Mosconi, Marten Beeg, Marcella Catania, Giacomina Rossi, Fabrizio Tagliavini, Giuseppe Di Fede & Mario Salmona. (2023) Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury. Molecular Psychiatry 28:6, pages 2433-2444.
Crossref
Crossref
Shivani Gupta & Ashok Kumar Dasmahapatra. (2023) Lycopene Destabilizes Preformed Aβ Fibrils: Mechanistic Insights from All-Atom Molecular Dynamics Simulation. Computational Biology and Chemistry, pages 107903.
Crossref
Crossref
Max Walton-Raaby, Riley Woods & Subha Kalyaanamoorthy. (2023) Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer’s Disease. International Journal of Molecular Sciences 24:11, pages 9476.
Crossref
Crossref
Diptaraj S. Chaudhari, Shalini Jain, Vinod K. Yata, Sidharth P. Mishra, Ambuj Kumar, Amoy Fraser, Judyta Kociolek, Mariana Dangiolo, Amanda Smith, Adam Golden, Michal M. Masternak, Peter Holland, Marc Agronin, Cynthia White-Williams, Andrea Y. Arikawa, Corinne A. Labyak & Hariom Yadav. (2023) Unique trans-kingdom microbiome structural and functional signatures predict cognitive decline in older adults. GeroScience 45:5, pages 2819-2834.
Crossref
Crossref
Jie Xu, Fei Wang, Chengxi Zang, Hao Zhang, Kellyann Niotis, Ava L. Liberman, Cynthia M. Stonnington, Makoto Ishii, Prakash Adekkanattu, Yuan Luo, Chengsheng Mao, Luke V. Rasmussen, Zhenxing Xu, Pascal Brandt, Jennifer A. Pacheco, Yifan Peng, Guoqian Jiang, Richard Isaacson & Jyotishman Pathak. (2023) Comparing the effects of four common drug classes on the progression of mild cognitive impairment to dementia using electronic health records. Scientific Reports 13:1.
Crossref
Crossref
Farzaneh Rahmani, Laura Ghezzi, Valeria Tosti, Jingxia Liu, Sheng-Kwei Song, Anthony T. Wu, Jayashree Rajamanickam, Kathleen A. Obert, Tammie L.S. Benzinger, Bettina Mittendorfer, Laura Piccio & Cyrus A. Raji. (2023) Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer’s Disease. Journal of Alzheimer's Disease 93:1, pages 263-273.
Crossref
Crossref
Yasmin Hollenbenders, Monika Pobiruchin & Alexandra Reichenbach. (2023) Two Routes to Alzheimer’s Disease Based on Differential Structural Changes in Key Brain Regions. Journal of Alzheimer's Disease 92:4, pages 1399-1412.
Crossref
Crossref
Aleksandra Petrovskaya, Artem Tverskoi, Angela Medvedeva & Maria Nazarova. (2023) Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?. Communications Biology 6:1.
Crossref
Crossref
Mahvish Faisal, Jana Aid, Bekzod Nodirov, Benjamin Lee & Miriam A. Hickey. (2023) Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice. PLOS ONE 18:4, pages e0281003.
Crossref
Crossref
Wayne Chadwick, Stuart Maudsley, William Hull, Enes Havolli, Eugene Boshoff, Mark D. W. Hill, Pascal J. D. Goetghebeur, David C. Harrison, Sohaib Nizami, David C. Bedford, Gareth Coope, Katia Real, Christoph Thiemermann, Peter Maycox, Mark Carlton & Sarah L. Cole. (2023) The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer’s Disease. International Journal of Molecular Sciences 24:8, pages 6953.
Crossref
Crossref
Sreevani Katabathula, Pamela B. Davis & Rong Xu. (2022) Comorbidity‐driven multi‐modal subtype analysis in mild cognitive impairment of Alzheimer's disease. Alzheimer's & Dementia 19:4, pages 1428-1439.
Crossref
Crossref
Steven F. Grieco, Todd C. Holmes & Xiangmin Xu. (2023) Probing neural circuit mechanisms in Alzheimer’s disease using novel technologies. Molecular Psychiatry.
Crossref
Crossref
Xiwu Wang, Teng Ye, Wenjun Zhou & Jie Zhang. (2023) Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach. Alzheimer's Research & Therapy 15:1.
Crossref
Crossref
Lindsay J. Marshall, Jarrod Bailey, Manuela Cassotta, Kathrin Herrmann & Francesca Pistollato. (2023) Poor Translatability of Biomedical Research Using Animals — A Narrative Review. Alternatives to Laboratory Animals 51:2, pages 102-135.
Crossref
Crossref
Giovanni Oliveros, Charles H Wallace, Osama Chaudry, Qiao Liu, Yue Qiu, Lei Xie, Patricia Rockwell, Maria E Figueiredo-Pereira & Peter A Serrano. (2023) Repurposing ibudilast to mitigate Alzheimer’s disease by targeting inflammation. Brain 146:3, pages 898-911.
Crossref
Crossref
Birsu Bac, Cheima Hicheri, Craig Weiss, Amelia Buell, Natalia Vilcek, Claudia Spaeni, Changiz Geula, Jeffrey N. Savas & John F. Disterhoft. (2023) The TgF344-AD rat: behavioral and proteomic changes associated with aging and protein expression in a transgenic rat model of Alzheimer's disease. Neurobiology of Aging 123, pages 98-110.
Crossref
Crossref
Pooja Jadiya, Henry M. Cohen, Devin W. Kolmetzky, Ashlesha A. Kadam, Dhanendra Tomar & John W. Elrod. (2023) Neuronal loss of NCLX-dependent mitochondrial calcium efflux mediates age-associated cognitive decline. iScience 26:3, pages 106296.
Crossref
Crossref
Kendall B.E. Moore, Ta-Jung Hung & Jessica S. Fortin. (2023) Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies. Drug Discovery Today 28:3, pages 103487.
Crossref
Crossref
Nikhila Shekhar, Sakshi Tyagi, Sweta Rani & Ajit Kumar Thakur. (2022) Potential of Capric Acid in Neurological Disorders: An Overview. Neurochemical Research 48:3, pages 697-712.
Crossref
Crossref
Giulio Nittari, Daniele Tomassoni, Proshanta Roy, Ilenia Martinelli, Seyed Khosrow Tayebati & Francesco Amenta. (2022) Batten disease through different in vivo and in vitro models: A review. Journal of Neuroscience Research 101:3, pages 298-315.
Crossref
Crossref
Prechiel A. Barredo & Mannix P. Balanay. (2023) Recent Advances in Molecular Dynamics Simulations of Tau Fibrils and Oligomers. Membranes 13:3, pages 277.
Crossref
Crossref
Sayali V. Gore, Rohit Kakodkar, Thaís Del Rosario Hernández, Sara Tucker Edmister & Robbert Creton. (2023) Zebrafish Larvae Position Tracker (Z-LaP Tracker): a high-throughput deep-learning behavioral approach for the identification of calcineurin pathway-modulating drugs using zebrafish larvae. Scientific Reports 13:1.
Crossref
Crossref
Rhayun Song, Xing Fan & Jisu Seo. (2023) Physical and cognitive function to explain the quality of life among older adults with cognitive impairment: exploring cognitive function as a mediator. BMC Psychology 11:1.
Crossref
Crossref
Anna Mathew, Vignesh Balaji E, Sreedhara Ranganath K. Pai, Anoop Kishore, Vasudev Pai, Ramadevi Pemmireddy & Chandrashekar K.S. (2023) Current Drug Targets in Alzheimer’s Associated Memory Impairment: A
Comprehensive Review. CNS & Neurological Disorders - Drug Targets 22:2, pages 255-275.
Crossref
Crossref
Jianchun Xiao, Ye Li, Treva Rowley, Jing Huang, Robert H. Yolken & Raphael P. Viscidi. (2023) Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection. Scientific Reports 13:1.
Crossref
Crossref
Rammohan V. Rao, Kaavya G. Subramaniam, Julie Gregory, Aida L. Bredesen, Christine Coward, Sho Okada, Lance Kelly & Dale E. Bredesen. (2023) Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review. International Journal of Molecular Sciences 24:2, pages 1659.
Crossref
Crossref
Antonio Chiariello, Sabrina Valente, Gianandrea Pasquinelli, Alessandra Baracca, Gianluca Sgarbi, Giancarlo Solaini, Valentina Medici, Valentina Fantini, Tino Emanuele Poloni, Monica Tognocchi, Marina Arcaro, Daniela Galimberti, Claudio Franceschi, Miriam Capri, Stefano Salvioli & Maria Conte. (2023) The expression pattern of GDF15 in human brain changes during aging and in Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Rekha S. Patel, Ashley Lui, Charles Hudson, Lauren Moss, Robert P. Sparks, Shannon E. Hill, Yan Shi, Jianfeng Cai, Laura J. Blair, Paula C. Bickford & Niketa A. Patel. (2023) Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model. Scientific Reports 13:1.
Crossref
Crossref
Mikhail V. Voronin, Elena V. Abramova, Ekaterina R. Verbovaya, Yulia V. Vakhitova & Sergei B. Seredenin. (2023) Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection. International Journal of Molecular Sciences 24:1, pages 823.
Crossref
Crossref
Jin-Hyuck Park. (2023) Effects of Personalized Cognitive Training Using Mental Workload Monitoring on Executive Function in Older Adults With Mild Cognitive Impairment. Brain & Neurorehabilitation 16:3.
Crossref
Crossref
F M Javed Mehedi Shamrat, Shamima Akter, Sami Azam, Asif Karim, Pronab Ghosh, Zarrin Tasnim, Khan Md. Hasib, Friso De Boer & Kawsar Ahmed. (2023) AlzheimerNet: An Effective Deep Learning Based Proposition for Alzheimer’s Disease Stages Classification From Functional Brain Changes in Magnetic Resonance Images. IEEE Access 11, pages 16376-16395.
Crossref
Crossref
Makis Tzioras, Robert I. McGeachan, Claire S. Durrant & Tara L. Spires-Jones. (2022) Synaptic degeneration in Alzheimer disease. Nature Reviews Neurology 19:1, pages 19-38.
Crossref
Crossref
Sopak Supakul, Yuki Hatakeyama, Nicolas Leventoux, Maika Itsuno, Naoko Numata, Hayato Hiramine, Satoru Morimoto, Atsushi Iwata, Sumihiro Maeda & Hideyuki Okano. (2023) Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs. Aging Brain 4, pages 100101.
Crossref
Crossref
Christian BehlChristian Behl. 2023. Alzheimer’s Disease Research. Alzheimer’s Disease Research
309
350
.
Valentin K. Gribkoff & Leonard K. Kaczmarek. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry
255
285
.
Raju Dash, Yeasmin Akter Munni, Sarmistha Mitra, Nayan Dash & Il Soo Moon. 2023. Computational Modeling of Drugs Against Alzheimer’s Disease. Computational Modeling of Drugs Against Alzheimer’s Disease
433
463
.
Vikram Venkatraghavan, Sebastian R. van der Voort, Daniel Bos, Marion Smits, Frederik Barkhof, Wiro J. Niessen, Stefan Klein & Esther E. Bron. 2023. Machine Learning for Brain Disorders. Machine Learning for Brain Disorders
459
490
.
Vidya Ramakrishnan, Christina Friedrich, Colleen Witt, Robert Sheehan, Meghan Pryor, Jasvinder K. Atwal, Kristin Wildsmith, Katherine Kudrycki, Seung‐Hye Lee, Norman Mazer, Carsten Hofmann, Reina N. Fuji, Jin Y. Jin, Saroja Ramanujan, Michael Dolton & Angelica Quartino. (2022) Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates. CPT: Pharmacometrics & Systems Pharmacology 12:1, pages 62-73.
Crossref
Crossref
Puja Chopade, Neha Chopade, Zongmin Zhao, Samir Mitragotri, Rick Liao & Vineeth Chandran Suja. (2022) Alzheimer's and Parkinson's disease therapies in the clinic. Bioengineering & Translational Medicine 8:1.
Crossref
Crossref
Oh-Yun Kwon & Seung-Ho Lee. (2022) Ishige okamurae Attenuates Neuroinflammation and Cognitive Deficits in Mice Intracerebroventricularly Injected with LPS via Regulating TLR-4/MyD88-Dependent Pathways. Antioxidants 12:1, pages 78.
Crossref
Crossref
Yanli Zhang, Xinmiao Li, Yu Yang & Tao Wang. (2022) Disease- and Drug-Related Knowledge Extraction for Health Management from Online Health Communities Based on BERT-BiGRU-ATT. International Journal of Environmental Research and Public Health 19:24, pages 16590.
Crossref
Crossref
Abduljelil Ajala, Adamu Uzairu, Gideon A. Shallangwa & Stephen E. Abechi. (2022) 2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
S. Saunders, S. Sheehan, G. Muniz-Terrera, S. Luz & C. W. Ritchie. (2022) Impact of clinical symptoms and diagnosis: the electronic Person-Specific Outcome Measure (ePSOM) development programme. Journal of Patient-Reported Outcomes 6:1.
Crossref
Crossref
Isabelle Aillaud, Senthilvelrajan Kaniyappan, Ram Reddy Chandupatla, Lisa Marie Ramirez, Sewar Alkhashrom, Jutta Eichler, Anselm H. C. Horn, Markus Zweckstetter, Eckhard Mandelkow, Heinrich Sticht & Susanne Aileen Funke. (2022) A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro. Alzheimer's Research & Therapy 14:1.
Crossref
Crossref
Nithya Krishnamurthy, Alyssa A. Grimshaw, Sydney A. Axson, Sung Hee Choe & Jennifer E. Miller. (2022) Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Services Research 22:1.
Crossref
Crossref
Juliette Helene Lanskey, Ece Kocagoncu, Andrew J Quinn, Yun-Ju Cheng, Melek Karadag, Jemma Pitt, Stephen Lowe, Michael Perkinton, Vanessa Raymont, Krish D Singh, Mark Woolrich, Anna C Nobre, Richard N Henson & James B Rowe. (2022) New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol. BMJ Open 12:12, pages e055135.
Crossref
Crossref
Marcella Catania, Laura Colombo, Stefano Sorrentino, Alfredo Cagnotto, Jacopo Lucchetti, Maria Chiara Barbagallo, Ilaria Vannetiello, Elena Rita Vecchi, Monica Favagrossa, Massimo Costanza, Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini & Giuseppe Di Fede. (2022) A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease. Molecular Psychiatry 27:12, pages 5227-5234.
Crossref
Crossref
Ryan A. Mace, Sarah W. Hopkins, Gretchen O. Reynolds & Ana-Maria Vranceanu. (2022) My Healthy Brain: Rationale and Case Report of a Virtual Group Lifestyle Program Targeting Modifiable Risk Factors for Dementia. Journal of Clinical Psychology in Medical Settings 29:4, pages 818-830.
Crossref
Crossref
Rawan Al‐kharboosh, Jonathan Jude Perera, Alexandra Bechtle, Guojun Bu & Alfredo Quinones‐Hinojosa. (2022) Emerging point‐of‐care autologous cellular therapy using adipose‐derived stromal vascular fraction for neurodegenerative diseases. Clinical and Translational Medicine 12:12.
Crossref
Crossref
Rawan Tarawneh, Rachel S. Kasper, Jessie Sanford, Chia‐Ling Phuah, Jason Hassenstab & Carlos Cruchaga. (2022) Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease. Annals of Clinical and Translational Neurology 9:12, pages 1926-1940.
Crossref
Crossref
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara & Abdel Qader Al Bawab. (2022) A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics. Diagnostics 12:12, pages 2975.
Crossref
Crossref
Jinjing Yao & S. R. Wayne Chen. (2022) R-carvedilol, a potential new therapy for Alzheimer’s disease. Frontiers in Pharmacology 13.
Crossref
Crossref
John Olichney, Jiangyi Xia, Kevin J. Church & Hans J. Moebius. (2022) Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential. Neural Plasticity 2022, pages 1-13.
Crossref
Crossref
Jessica S. Fortin, Kazuma Shimanaka, A Prasanth Saraswati, Mengyu Liu, Kuang-Wei Wang, Hsiao-Tien Hagar, Soham Maity, Susantha K. Ganegamage, Edmund Ellsworth, Scott E. Counts, Babak Borhan, Ulf Dettmer & Min-Hao Kuo. (2022) Anti-fibrillization effects of sulfonamide derivatives on α-synuclein and hyperphosphorylated tau isoform 1N4R. Journal of Molecular Structure 1267, pages 133574.
Crossref
Crossref
Giuseppe Pasqualetti, Tony Thayanandan & Paul Edison. (2022) Influence of genetic and cardiometabolic risk factors in Alzheimer’s disease. Ageing Research Reviews 81, pages 101723.
Crossref
Crossref
Maxim N. Shokhirev & Adiv A. Johnson. (2022) An integrative machine-learning meta-analysis of high-throughput omics data identifies age-specific hallmarks of Alzheimer’s disease. Ageing Research Reviews 81, pages 101721.
Crossref
Crossref
Noriyasu Kamei, Ayaka Hashimoto, Erina Tanaka, Kaho Murata, Maika Yamaguchi, Natsuki Yokoyama, Masahiro Kato, Keisuke Oki, Takashi Saito, Takaomi C. Saido & Mariko Takeda-Morishita. (2022) Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer’s disease mouse model. Drug Delivery and Translational Research 12:11, pages 2667-2677.
Crossref
Crossref
Ujala Sehar, Priyanka Rawat, Arubala P. Reddy, Jonathan Kopel & P. Hemachandra Reddy. (2022) Amyloid Beta in Aging and Alzheimer’s Disease. International Journal of Molecular Sciences 23:21, pages 12924.
Crossref
Crossref
Sravan Gopalkrishnashetty Sreenivasmurthy, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, Rambabu N. Reddi, Ananth Kumar Kammala, Karthick Vasudevan, Sanjib Senapati, Zhou Zhu, Cheng-Fu Su, Jia Liu, Xin-Jie Guan, Ka-Kit Chua, King-Ho Cheung, Hubiao Chen, Hong-Jie Zhang, Yuan Zhang, Ju-Xian Song, Siva Sundara Kumar Durairajan & Min Li. (2022) Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Sai S. Pradhan, Sai M. Thota, Saiswaroop Rajaratnam, Sai K. S. Bhagavatham, Sujith K. Pulukool, Sriram Rathnakumar, Kanikaram S. Phalguna, Rajesh B. Dandamudi, Ashish Pargaonkar, Prasanth Joseph, E. V. Joshy & Venketesh Sivaramakrishnan. (2022) Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation. Disease Models & Mechanisms 15:10.
Crossref
Crossref
Yuanyuan Qin, Fengxia Zhang, Min Zhang & Wenzhen Zhu. (2022) Effects of repetitive transcranial magnetic stimulation combined with cognitive training on resting-state brain activity in Alzheimer’s disease. The Neuroradiology Journal 35:5, pages 566-572.
Crossref
Crossref
Carolina S. Marques, Óscar López, Luisa Leitzbach, José G. Fernández-Bolaños, Holger Stark & Anthony J. Burke. (2022) Survey of New, Small-Molecule Isatin-Based Oxindole Hybrids as Multi-Targeted Drugs for the Treatment of Alzheimer’s Disease. Synthesis 54:19, pages 4304-4319.
Crossref
Crossref
Mantas Ziaunys, Andrius Sakalauskas, Kamile Mikalauskaite & Vytautas Smirnovas. (2022) Rapid restructurization of conformationally-distinct alpha-synuclein amyloid fibrils at an elevated temperature. PeerJ 10, pages e14137.
Crossref
Crossref
Yeqing Dong, Tongxin Li, Zhonghui Ma, Chi Zhou, Xinxu Wang & Jie Li. (2022) HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer’s Disease. Disease Markers 2022, pages 1-16.
Crossref
Crossref
Linyan Wu, Tiantian Cao, Sinan Li, Ye Yuan, Wenlong Zhang, Liang Huang, Chujie Cai, Liming Fan, Long Li, Jingyun Wang, Tian Liu & Jue Wang. (2022) Long-term gamma transcranial alternating current stimulation improves the memory function of mice with Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Aaron Reuben, Terrie E Moffitt, Wickliffe C Abraham, Antony Ambler, Maxwell L Elliott, Ahmad R Hariri, Honalee Harrington, Sean Hogan, Renate M Houts, David Ireland, Annchen R Knodt, Joan Leung, Amber Pearson, Richie Poulton, Suzanne C Purdy, Sandhya Ramrakha, Line J H Rasmussen, Karen Sugden, Peter R Thorne, Benjamin Williams, Graham Wilson & Avshalom Caspi. (2022) Improving risk indexes for Alzheimer’s disease and related dementias for use in midlife. Brain Communications 4:5.
Crossref
Crossref
Happy Isibor, Abayomi Mayowa Ajayi, Benneth Ben-Azu, Noah Adavize Omeiza, Adeleke Paul Ademola & Solomon Umukoro. (2022) D-ribose-L-cysteine reduces oxidative stress and inflammatory cytokines to mitigate liver damage, and memory decline induced by copper sulfate in mice. Journal of Trace Elements in Medicine and Biology 73, pages 127001.
Crossref
Crossref
Nian-Siou Wu, Yi-Fan Lin, I. Chu Ma, Huey-Jiun Ko & Yi-Ren Hong. (2022) Many faces and functions of GSKIP: a temporospatial regulation view. Cellular Signalling 97, pages 110391.
Crossref
Crossref
Alexander S. F. Doney, Aditya Nar, Yu Huang, Emanuele Trucco, Tom MacGillivray, Peter Connelly, Graham P. Leese & Gareth J. McKay. (2022) Retinal vascular measures from diabetes retinal screening photographs and risk of incident dementia in type 2 diabetes: A GoDARTS study. Frontiers in Digital Health 4.
Crossref
Crossref
Giacomo Dentoni, Laura Castro-Aldrete, Luana Naia & Maria Ankarcrona. (2022) The Potential of Small Molecules to Modulate the Mitochondria–Endoplasmic Reticulum Interplay in Alzheimer’s Disease. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Yu-Kai Chang, Kirk I. Erickson, Sarah L. Aghjayan, Feng-Tzu Chen, Ruei-Hong Li, Jia-Ru Shih, Shao-Hsi Chang, Chih-Mao Huang & Chien-Heng Chu. (2022) The multi-domain exercise intervention for memory and brain function in late middle-aged and older adults at risk for Alzheimer's disease: A protocol for Western–Eastern Brain Fitness Integration Training trial. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Bowen TangYunzhang WangXia Jiang, Madhav ThambisettyLuigi FerrucciKristina JohnellSara Hägg. (2022) Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk. Neurology 99:7.
Crossref
Crossref
Sean Tok, Abdallah Ahnaou & Wilhelmus Drinkenburg. (2022) Functional Neurophysiological Biomarkers of Early-Stage Alzheimer’s Disease: A Perspective of Network Hyperexcitability in Disease Progression. Journal of Alzheimer's Disease 88:3, pages 809-836.
Crossref
Crossref
Sankar Muthukumar, Karnika Mehrotra, Mohammed Fouda, Sarah Hamimi, Lauren L. Jantzie & Shenandoah Robinson. (2022) Prenatal and postnatal insults differentially contribute to executive function and cognition: Utilizing touchscreen technology for perinatal brain injury research. Experimental Neurology 354, pages 114104.
Crossref
Crossref
Laura Blaikie, Graeme Kay, Patricia Maciel & Paul Kong Thoo Lin. (2022) Experimental modelling of Alzheimer's disease for therapeutic screening. European Journal of Medicinal Chemistry Reports 5, pages 100044.
Crossref
Crossref
Hongjie Wang, Dinesh Devadoss, Madhavan Nair, Hitendra S. Chand & Madepalli K. Lakshmana. (2022) Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Elena Puris, Seppo Auriola, Sabrina Petralla, Robin Hartman, Mikko Gynther, Elizabeth C.M. de Lange & Gert Fricker. (2022) Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model. Neurobiology of Disease 169, pages 105741.
Crossref
Crossref
Zigmantas Toleikis, Raitis Bobrovs, Agne Janoniene, Alons Lends, Mantas Ziaunys, Ieva Baronaite, Vytautas Petrauskas, Kristine Kitoka, Vytautas Smirnovas & Kristaps Jaudzems. (2022) Interactions between S100A9 and Alpha-Synuclein: Insight from NMR Spectroscopy. International Journal of Molecular Sciences 23:12, pages 6781.
Crossref
Crossref
Sherri Dudal, Caterina Bissantz, Antonello Caruso, Pascale David-Pierson, Wouter Driessen, Erich Koller, Ben-Fillippo Krippendorff, Martin Lechmann, Andrés Olivares-Morales, Axel Paehler, Caroline Rynn, Dietrich Türck, Arthur Van De Vyver, Ken Wang & Lotte Winther. (2022) Translating pharmacology models effectively to predict therapeutic benefit. Drug Discovery Today 27:6, pages 1604-1621.
Crossref
Crossref
An Li, Yuntao Chen, Anita Visser, Luc A.M. Marks & Geerten‐Has E. Tjakkes. (2021) Combined association of cognitive impairment and poor oral health on mortality risk in older adults: Results from the NHANES with 15 years of follow‐up. Journal of Periodontology 93:6, pages 888-900.
Crossref
Crossref
Jarrad M. Scarlett, Shannon J. Hu & Kimberly M. Alonge. (2022) The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?. Frontiers in Integrative Neuroscience 16.
Crossref
Crossref
Merav Antman-Passig, Eitan Wong, Georgia R. Frost, Christian Cupo, Janki Shah, Albert Agustinus, Ziyu Chen, Chiara Mancinelli, Maikel Kamel, Thomas Li, Lauren A. Jonas, Yue-Ming Li & Daniel A. Heller. (2022) Optical Nanosensor for Intracellular and Intracranial Detection of Amyloid-Beta. ACS Nano 16:5, pages 7269-7283.
Crossref
Crossref
Kamile Mikalauskaite, Mantas Ziaunys & Vytautas Smirnovas. (2022) Lysozyme Amyloid Fibril Structural Variability Dependence on Initial Protein Folding State. International Journal of Molecular Sciences 23:10, pages 5421.
Crossref
Crossref
Aric F. Logsdon, Kendra L. Francis, Nicole E. Richardson, Shannon J. Hu, Chelsea L. Faber, Bao Anh Phan, Vy Nguyen, Naly Setthavongsack, William A. Banks, Randy L. Woltjer, C. Dirk Keene, Caitlin S. Latimer, Michael W. Schwartz, Jarrad M. Scarlett & Kimberly M. Alonge. (2021) Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain. Alzheimer's & Dementia 18:5, pages 942-954.
Crossref
Crossref
Sara Tucker Edmister, Thaís Del Rosario Hernández, Rahma Ibrahim, Cameron A. Brown, Sayali V. Gore, Rohit Kakodkar, Jill A. Kreiling & Robbert Creton. (2022) Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles. Scientific Reports 12:1.
Crossref
Crossref
Sarthak Prashant Mehta & Ramachandran Balaraman. (2022) A Review on Herbal Remedies for Alzheimer’s Disease. Journal of Natural Remedies 22:2, pages 123.
Crossref
Crossref
Anastasiia Ilina, Vladimir Khavinson, Natalia Linkova & Mikhael Petukhov. (2022) Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease. International Journal of Molecular Sciences 23:8, pages 4259.
Crossref
Crossref
Prashant Poudel & Soyeun Park. (2022) Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics 14:4, pages 835.
Crossref
Crossref
Jahirul Islam, Jung-Ah Cho, Ju-yong Kim, Kyung-Sun Park, Young-Jae Koh, Chu Young Chung, Eun-Jae Lee, Soo Jeong Nam, Kyoungyul Lee, Seoung-Heon Kim, Sung-Hye Park, Dong Young Lee, Byeong C. Kim, Kyung-Hwa Lee & Seung-Yong Seong. (2022) GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in a Mouse Model of Alzheimer’s Disease. Frontiers in Immunology 13.
Crossref
Crossref
Zeyu Zhu, Junfeng Lu, Shuyi Wang, Weijia Peng, Yang Yang, Chen Chen, Xin Zhou, Xifei Yang, Wenjun Xin, Xinyi Chen, Jiakai Pi, Wei Yin, Lin Yao & Rongbiao Pi. (2022) Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway. Aging Cell 21:4.
Crossref
Crossref
Linda Giampietri, Elisabetta Belli, Maria Francesca Beatino, Sara Giannoni, Giovanni Palermo, Nicole Campese, Gloria Tognoni, Gabriele Siciliano, Roberto Ceravolo, Ciro De Luca & Filippo Baldacci. (2022) Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments. Diagnostics 12:4, pages 796.
Crossref
Crossref
Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim & Rudolph E. Tanzi. (2022) Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease. Frontiers in Neuroscience 16.
Crossref
Crossref
C. Kwon Kim, Yin Rui Lee, Lynnett Ong, Michael Gold, Amir Kalali & Joydeep Sarkar. (2022) Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures. Journal of Alzheimer's Disease, pages 1-18.
Crossref
Crossref
Jessica L. Dennison, Claude-Henry Volmar, Farzaneh Modarresi, Danbing Ke, James Wang, Emilie Gravel, Sabrina Hammond-Vignini, Zuomei Li, James A. Timmons, Ines Lohse, Marshall A. Hayward, Shaun P. Brothers & Claes Wahlestedt. (2022) JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1. Journal of Alzheimer's Disease 86:1, pages 173-190.
Crossref
Crossref
Todd E. Golde. (2022) Alzheimer’s disease – the journey of a healthy brain into organ failure. Molecular Neurodegeneration 17:1.
Crossref
Crossref
Johan A. den Boer, Erik J.F. de Vries, Ronald J.H. Borra, Aren van Waarde, Adriaan A. Lammertsma & Rudi A. Dierckx. (2022) Role of Brain Imaging in Drug Development for Psychiatry. Current Reviews in Clinical and Experimental Pharmacology 17:1, pages 46-71.
Crossref
Crossref
Mabel Seto, Emily R. Mahoney, Logan Dumitrescu, Vijay K. Ramanan, Corinne D. Engelman, Yuetiva Deming, Marilyn Albert, Sterling C. Johnson, Henrik Zetterberg, Kaj Blennow, Prashanthi Vemuri, Angela L. Jefferson & Timothy J. Hohman. (2022) Exploring common genetic contributors to neuroprotection from amyloid pathology. Brain Communications 4:2.
Crossref
Crossref
Vanessa Lage-Rupprecht, Bruce Schultz, Justus Dick, Marcin Namysl, Andrea Zaliani, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Bernhard Ellinger, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen & Martin Hofmann-Apitius. (2022) A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism. Patterns 3:3, pages 100433.
Crossref
Crossref
Meiyang Xi, Tianyu Sun, Shejie Chai, Mengjiao Xie, Siqi Chen, Liping Deng, Kui Du, Runpu Shen & Haopeng Sun. (2022) Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease. European Journal of Medicinal Chemistry 232, pages 114170.
Crossref
Crossref
Steven G. Fagan, Sibylle Bechet & Kumlesh K. Dev. (2022) Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease. Molecular Neurobiology 59:3, pages 1882-1895.
Crossref
Crossref
Ened Rodríguez-Urgellés, Anna Sancho-Balsells, Wanqi Chen, Laura López-Molina, Ivan Ballasch, Ignacio del Castillo, Conxita Avila, Jordi Alberch & Albert Giralt. (2022) Meridianins Rescue Cognitive Deficits, Spine Density and Neuroinflammation in the 5xFAD Model of Alzheimer’s Disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Süleyman Yıldırım, Özkan Ufuk Nalbantoğlu, Abdulahad Bayraktar, Fatma Betül Ercan, Aycan Gündoğdu, Halil Aziz Velioğlu, Mehmet Fatih Göl, Ayten Ekinci Soylu, Fatma Koç, Ezgi Aslan Gülpınar, Kübra Sogukkanlı Kadak, Muzaffer Arıkan, Adil Mardinoğlu, Mehmet Koçak, Emel Köseoğlu & Lütfü Hanoğlu. (2022) Stratification of the Gut Microbiota Composition Landscape across the Alzheimer's Disease Continuum in a Turkish Cohort. mSystems 7:1.
Crossref
Crossref
Dona P. W. Jayatunga, Eugene Hone, W. M. A. D. Binosha Fernando, Manohar L. Garg, Giuseppe Verdile & Ralph N. Martins. (2022) A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer’s Disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Alexandra J. Noble, Rachel V. Purcell, Alex T. Adams, Ying K. Lam, Paulina M. Ring, Jessica R. Anderson & Amy J. Osborne. (2022) A Final Frontier in Environment-Genome Interactions? Integrated, Multi-Omic Approaches to Predictions of Non-Communicable Disease Risk. Frontiers in Genetics 13.
Crossref
Crossref
Jinghan Jenny Chen, Mathura Thiyagarajah, Jianmeng Song, Clara Chen, Nathan Herrmann, Damien Gallagher, Mark J. Rapoport, Sandra E. Black, Joel Ramirez, Ana C. Andreazza, Paul Oh, Susan Marzolini, Simon J. Graham & Krista L. Lanctôt. (2022) Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis. Alzheimer's Research & Therapy 14:1.
Crossref
Crossref
Koh Tadokoro, Toru Yamashita, Junko Sato, Yoshio Omote, Mami Takemoto, Ryuta Morihara, Koichiro Nishiura, Tomiko Tani & Koji Abe. (2022) Chronic Beneficial Effect of Makeup Therapy on Cognitive Function of Dementia and Facial Appearance Analyzed by Artificial Intelligence Software. Journal of Alzheimer's Disease 85:3, pages 1189-1194.
Crossref
Crossref
Hayrettin Ozan Gulcan & Muberra Kosar. (2022) The Hybrid Compounds as Multi-target Ligands for the Treatment of
Alzheimer's Disease: Considerations on Donepezil. Current Topics in Medicinal Chemistry 22:5, pages 395-407.
Crossref
Crossref
Marlon V. Duro, Brandon Ebright & Hussein N. Yassine. (2022) Lipids and brain inflammation in APOE4-associated dementia. Current Opinion in Lipidology 33:1, pages 16-24.
Crossref
Crossref
Ivan A. Kuznetsov & Andrey V. Kuznetsov. (2022) Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?. Mathematical Biosciences 344, pages 108754.
Crossref
Crossref
Chenmala Karthika, Anoop Pattanoor Appu, Rokeya Akter, Md. Habibur Rahman, Priti Tagde, Ghulam Md. Ashraf, Mohamed M. Abdel-Daim, Syed Shams ul Hassan, Areha Abid & Simona Bungau. (2022) Potential innovation against Alzheimer’s disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery. Environmental Science and Pollution Research 29:8, pages 10950-10965.
Crossref
Crossref
Jianfeng Wu, Yanxi Chen, Panwen Wang, Richard J. Caselli, Paul M. Thompson, Junwen Wang & Yalin Wang. (2022) Integrating Transcriptomics, Genomics, and Imaging in Alzheimer's Disease: A Federated Model. Frontiers in Radiology 1.
Crossref
Crossref
Matthias Berkes & Ellen Bialystok. (2022) Bilingualism as a Contributor to Cognitive Reserve: What it Can do and What it Cannot do. American Journal of Alzheimer's Disease & Other Dementias® 37, pages 153331752210914.
Crossref
Crossref
Ozlem Muslu, Charles Tapley Hoyt, Mauricio Lacerda, Martin Hofmann-Apitius & Holger Frohlich. (2022) GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning. IEEE/ACM Transactions on Computational Biology and Bioinformatics 19:1, pages 491-500.
Crossref
Crossref
Katie J Smith & Emily Gwyer Findlay. (2022) Expression of antimicrobial host defence peptides in the central nervous system during health and disease. Discovery Immunology 1:1.
Crossref
Crossref
Mantas Ziaunys, Kamile Mikalauskaite, Dominykas Veiveris, Andrius Sakalauskas & Vytautas Smirnovas. (2022) Superoxide dismutase-1 alters the rate of prion protein aggregation and resulting fibril conformation. Archives of Biochemistry and Biophysics 715, pages 109096.
Crossref
Crossref
Irena Loryan & Margareta Hammarlund-Udenaes. 2022. Drug Delivery to the Brain. Drug Delivery to the Brain
389
436
.
T. Fulop, A. Larbi, A. Khalil, A. Plotka, B. Laurent, C. Ramassamy, N. Bosco, K. Hirokawa, E. H. Frost & J. M. Witkowski. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
177
199
.
Jana Velíšková & Libor Velíšek. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
4399
4415
.
Iqra Pervaiz & Abraham J. Al-Ahmad. 2022. The Blood-Brain Barrier. The Blood-Brain Barrier
53
72
.
Whitaker Cohn, Mikhail Melnik, Calvin Huang, Bruce Teter, Sujyoti Chandra, Chunni Zhu, Laura Beth McIntire, Varghese John, Karen H. Gylys & Tina Bilousova. (2021) Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures. Frontiers in Pharmacology 12.
Crossref
Crossref
Pooja Jadiya, Joanne F. Garbincius & John W. Elrod. (2021) Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling. Acta Neuropathologica Communications 9:1.
Crossref
Crossref
Mincheol Park, Gia Minh Hoang, Thien Nguyen, Eunkyung Lee, Hyun Jin Jung, Youngshik Choe, Moon Hwan Lee, Jae Youn Hwang, Jae Gwan Kim & Tae Kim. (2021) Effects of transcranial ultrasound stimulation pulsed at 40 Hz on Aβ plaques and brain rhythms in 5×FAD mice. Translational Neurodegeneration 10:1.
Crossref
Crossref
Hyeon soo Kim, Sujin Kim, Soo Jung Shin, Yong Ho Park, Yunkwon Nam, Chae won Kim, Kang won Lee, Sung-Min Kim, In Duk Jung, Hyun Duk Yang, Yeong-Min Park & Minho Moon. (2021) Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications. Translational Neurodegeneration 10:1.
Crossref
Crossref
Jörg Mahlich, Arne Bartol & Srirangan Dheban. (2021) Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis. Health Economics Review 11:1.
Crossref
Crossref
Steve Rodriguez, Clemens Hug, Petar Todorov, Nienke Moret, Sarah A. Boswell, Kyle Evans, George Zhou, Nathan T. Johnson, Bradley T. Hyman, Peter K. Sorger, Mark W. Albers & Artem Sokolov. (2021) Machine learning identifies candidates for drug repurposing in Alzheimer’s disease. Nature Communications 12:1.
Crossref
Crossref
Galina Limorenko & Hilal A. Lashuel. (2021) To target Tau pathologies, we must embrace and reconstruct their complexities. Neurobiology of Disease 161, pages 105536.
Crossref
Crossref
Kian Chung Chok, Khuen Yen Ng, Rhun Yian Koh & Soi Moi Chye. (2021) Role of the gut microbiome in Alzheimer’s disease. Reviews in the Neurosciences 32:7, pages 767-789.
Crossref
Crossref
Mantas Ziaunys, Andrius Sakalauskas, Kamile Mikalauskaite & Vytautas Smirnovas. (2021) Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration. International Journal of Molecular Sciences 22:22, pages 12382.
Crossref
Crossref
Sopak Supakul, Hideyuki Okano & Sumihiro Maeda. (2021) Utilization of Human Induced Pluripotent Stem Cells-Derived In vitro Models for the Future Study of Sex Differences in Alzheimer’s Disease. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
Patrick G Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyt, Shona L Clegg, Ian B Malone, Josephine Barnes, Casper Nielsen, Carole H Sudre, Aileen Wilson, N Jade Thai, Peter S Blair, Elizabeth J Coulthard, J Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David L Thomas, Nick C Fox, Ian Wilkinson & Yoav Ben-Shlomo. (2021) Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT. Efficacy and Mechanism Evaluation 8:19, pages 1-72.
Crossref
Crossref
Ashleigh B. Irwin, Rudhab Bahabry & Farah D. Lubin. (2021) A putative role for lncRNAs in epigenetic regulation of memory. Neurochemistry International 150, pages 105184.
Crossref
Crossref
Eun-Jeong Yang, Hyunju Kim, Yunjung Choi, Hak Jae Kim, Jin Ho Kim, Jeongmin Yoon, Young-Seok Seo & Hye-Sun Kim. (2021) Modulation of Neuroinflammation by Low-Dose Radiation Therapy in an Animal Model of Alzheimer's Disease. International Journal of Radiation Oncology*Biology*Physics 111:3, pages 658-670.
Crossref
Crossref
Linda Blümel, Jan Brosda, Bettina Bert, Melanie Hamann & Gunnar P.H. Dietz. (2021) Moderately aged OFA rats as a novel model for mild age-related alterations in learning and memory. Brain and Cognition 154, pages 105799.
Crossref
Crossref
Adel A. Gomaa, Hanan A. Farghaly, Yasmin A. Abdel-Wadood & Ghada A. Gomaa. (2021) Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer’s disease. Naunyn-Schmiedeberg's Archives of Pharmacology 394:11, pages 2167-2185.
Crossref
Crossref
Mantas Ziaunys, Kamile Mikalauskaite, Andrius Sakalauskas & Vytautas Smirnovas. (2021) Interplay between epigallocatechin-3-gallate and ionic strength during amyloid aggregation. PeerJ 9, pages e12381.
Crossref
Crossref
Prechiel A. Barredo, Marvin Jose F. Fernandez, Christopher E. Ambe & Mannix P. Balanay. (2021) Tau fibril with membrane lipids: Insight from computational modeling and simulations. PLOS ONE 16:10, pages e0258692.
Crossref
Crossref
Yi-Long Huang, Chao-Hsiung Lin, Tsung-Hsien Tsai, Chen-Hua Huang, Jie-Ling Li, Liang-Kung Chen, Chun-Hsien Li, Ting-Fen Tsai & Pei-Ning Wang. (2021) Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer’s Disease. International Journal of Molecular Sciences 22:20, pages 10903.
Crossref
Crossref
Wojciech Michno, Kaj Blennow, Henrik Zetterberg & Gunnar Brinkmalm. (2021) Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma. Journal of Neurochemistry 159:2, pages 234-257.
Crossref
Crossref
Michael Wainberg, Tain Luquez, David M. Koelle, Ben Readhead, Christine Johnston, Martin Darvas & Cory C. Funk. (2021) The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease. Molecular Psychiatry 26:10, pages 5476-5480.
Crossref
Crossref
Shawn M. Luttrell, Alec S. T. Smith & David L. Mack. (2021) Creating stem cell‐derived neuromuscular junctions in vitro. Muscle & Nerve 64:4, pages 388-403.
Crossref
Crossref
Andrius Sakalauskas, Mantas Ziaunys, Ruta Snieckute & Vytautas Smirnovas. (2021) Autoxidation Enhances Anti-Amyloid Potential of Flavone Derivatives. Antioxidants 10:9, pages 1428.
Crossref
Crossref
Jēkabs Fridmanis, Zigmantas Toleikis, Tomas Sneideris, Mantas Ziaunys, Raitis Bobrovs, Vytautas Smirnovas & Kristaps Jaudzems. (2021) Aggregation Condition–Structure Relationship of Mouse Prion Protein Fibrils. International Journal of Molecular Sciences 22:17, pages 9635.
Crossref
Crossref
Chaahat S.B. Singh, Kyung Bok Choi, Lonna Munro, Hong Yue Wang, Cheryl G. Pfeifer & Wilfred A. Jefferies. (2021) Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. eBioMedicine 71, pages 103503.
Crossref
Crossref
Mantas Ziaunys, Kamile Mikalauskaite, Andrius Sakalauskas & Vytautas Smirnovas. (2021) Using lysozyme amyloid fibrils as a means of scavenging aggregation‐inhibiting compounds. Biotechnology Journal 16:9, pages 2100138.
Crossref
Crossref
Koh Tadokoro, Toru Yamashita, Satoko Kawano, Junko Sato, Yoshio Omote, Mami Takemoto, Ryuta Morihara, Koichiro Nishiura, Natsuki Sagawa, Tomiko Tani & Koji Abe. (2021) Immediate Beneficial Effect of Makeup Therapy on Behavioral and Psychological Symptoms of Dementia and Facial Appearance Analyzed by Artificial Intelligence Software. Journal of Alzheimer's Disease 83:1, pages 57-63.
Crossref
Crossref
Qianqian Li, Junkai Wang, Jianghong Liu, Yumeng Wang & Kuncheng Li. (2021) Magnetic Resonance Imaging Measurement of Entorhinal Cortex in the Diagnosis and Differential Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease. Brain Sciences 11:9, pages 1129.
Crossref
Crossref
Kevin J. Sullivan, Xinhui Ran, Fan Wu, Chung‐Chou H. Chang, Ravi Sharma, Erin Jacobsen, Sarah Berman, Beth E. Snitz, Akira Sekikawa, Evelyn O. Talbott & Mary Ganguli. (2021) Ambient fine particulate matter exposure and incident mild cognitive impairment and dementia. Journal of the American Geriatrics Society 69:8, pages 2185-2194.
Crossref
Crossref
Mara Zielinski, Christine Röder & Gunnar F. Schröder. (2021) Challenges in sample preparation and structure determination of amyloids by cryo-EM. Journal of Biological Chemistry 297:2, pages 100938.
Crossref
Crossref
Wei Wei, Yinghua Liu, Chun-Ling Dai, Narjes Baazaoui, Yunn Chyn Tung, Fei Liu & Khalid Iqbal. (2021) Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction. Journal of Alzheimer's Disease 82:2, pages 631-646.
Crossref
Crossref
Jonathan LiErnest Fraenkel. (2021) Phenotyping Neurodegeneration in Human iPSCs. Annual Review of Biomedical Data Science 4:1, pages 83-100.
Crossref
Crossref
Enrique Armijo, George Edwards, Andrea Flores, Jorge Vera, Mohammad Shahnawaz, Fabio Moda, Cesar Gonzalez, Magdalena Sanhueza & Claudio Soto. (2021) Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer’s Disease. Cells 10:7, pages 1802.
Crossref
Crossref
Li Yang Tan, Xin Yi Yeo, Han-Gyu Bae, Delia Pei Shan Lee, Roger C. Ho, Jung Eun Kim, Dong-Gyu Jo & Sangyong Jung. (2021) Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?. Life 11:7, pages 698.
Crossref
Crossref
Yanxian Zhang, Yonglan Liu, Yijing Tang, Dong Zhang, Huacheng He, Jiang Wu & Jie Zheng. (2021) Antimicrobial α-defensins as multi-target inhibitors against amyloid formation and microbial infection. Chemical Science 12:26, pages 9124-9139.
Crossref
Crossref
Vinod Jani, Uddhavesh Sonavane & Rajendra Joshi. (2021) Destabilization potential of beta sheet breaker peptides on Abeta fibril structure: an insight from molecular dynamics simulation study. RSC Advances 11:38, pages 23557-23573.
Crossref
Crossref
Carolina Costa-Rodrigues, Joana Couceiro & Eduardo Moreno. (2021) Cell competition from development to neurodegeneration. Disease Models & Mechanisms 14:7.
Crossref
Crossref
Daniel Palmer, Julie R. Dumont, Tyler D. Dexter, Marco A.M. Prado, Elizabeth Finger, Timothy J. Bussey & Lisa M. Saksida. (2021) Touchscreen cognitive testing: Cross-species translation and co-clinical trials in neurodegenerative and neuropsychiatric disease. Neurobiology of Learning and Memory 182, pages 107443.
Crossref
Crossref
Usma Munawara, Michael Catanzaro, Weili Xu, Crystal Tan, Katsuiku Hirokawa, Nabil Bosco, David Dumoulin, Abdelouahed Khalil, Anis Larbi, Simon Lévesque, Charles Ramassamy, Annelise E. Barron, Stephen Cunnane, Pascale B. Beauregard, Jean-Pierre Bellenger, Serafim Rodrigues, Mathieu Desroches, Jacek M. Witkowski, Benoit Laurent, Eric H. Frost & Tamas Fulop. (2021) Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease. Immunity & Ageing 18:1.
Crossref
Crossref
Mikaela Peglow Pinz, Ane Gabriela Vogt, Karline da Costa Rodrigues, Angélica Schiavom dos Reis, Luis Fernando Barbosa Duarte, Mariana Gallio Fronza, William Borges Domingues, Eduardo Bierhaus Blodorn, Diego Alves, Vinicius Farias Campos, Lucielli Savegnago, Ethel Antunes Wilhelm & Cristiane Luchese. (2021) Effect of a purine derivative containing selenium to improve memory decline and anxiety through modulation of the cholinergic system and Na+/K+-ATPase in an Alzheimer’s disease model. Metabolic Brain Disease 36:5, pages 871-888.
Crossref
Crossref
Mrinal K. Poddar, Soumyabrata Banerjee, Apala Chakraborty & Debasmita Dutta. (2021) Metabolic disorder in Alzheimer’s disease. Metabolic Brain Disease 36:5, pages 781-813.
Crossref
Crossref
Jessica Kho, P. Chi Pham, Suhyeon Kwon, Alana Y. Huang, Joel P. Rivers, Huixin Wang, Heath Ecroyd, W. Alexander Donald & Shelli R. McAlpine. (2021) De Novo Design, Synthesis, and Mechanistic Evaluation of Short Peptides That Mimic Heat Shock Protein 27 Activity. ACS Medicinal Chemistry Letters 12:5, pages 713-719.
Crossref
Crossref
Mantas Ziaunys, Andrius Sakalauskas, Kamile Mikalauskaite, Ruta Snieckute & Vytautas Smirnovas. (2021) Temperature-Dependent Structural Variability of Prion Protein Amyloid Fibrils. International Journal of Molecular Sciences 22:10, pages 5075.
Crossref
Crossref
Amy E Jolly & Adam Hampshire. (2021) A robust brain signature region approach for episodic memory performance in older adults. Brain 144:4, pages 1038-1040.
Crossref
Crossref
Kiri T. Granger & Jennifer H. Barnett. (2021) Postoperative cognitive dysfunction: an acute approach for the development of novel treatments for neuroinflammation. Drug Discovery Today 26:5, pages 1111-1114.
Crossref
Crossref
Hattapark Dejakaisaya, Anna Harutyunyan, Patrick Kwan & Nigel C. Jones. (2021) Altered metabolic pathways in a transgenic mouse model suggest mechanistic role of amyloid precursor protein overexpression in Alzheimer’s disease. Metabolomics 17:5.
Crossref
Crossref
Julie Gregory, Yasaswi V. Vengalasetti, Dale E. Bredesen & Rammohan V. Rao. (2021) Neuroprotective Herbs for the Management of Alzheimer’s Disease. Biomolecules 11:4, pages 543.
Crossref
Crossref
Halil Aziz Velioglu, Lutfu Hanoglu, Zubeyir Bayraktaroglu, Guven Toprak, Eray Metin Guler, Muhammed Yunus Bektay, Ozlem Mutlu-Burnaz & Burak Yulug. (2021) Left lateral parietal rTMS improves cognition and modulates resting brain connectivity in patients with Alzheimer’s disease: Possible role of BDNF and oxidative stress. Neurobiology of Learning and Memory 180, pages 107410.
Crossref
Crossref
Rosalyn Hithersay, R. Asaad Baksh, Carla M. Startin, Peter Wijeratne, Sarah Hamburg, Ben Carter & Andre Strydom. (2020) Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome. Alzheimer's & Dementia 17:4, pages 595-604.
Crossref
Crossref
Peng Zeng, Xiao-Ming Wang, Chao-Yuan Ye, Hong-Fei Su & Qing Tian. (2021) The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer’s Disease Mechanism Determined by a Network Pharmacology Approach. International Journal of Molecular Sciences 22:7, pages 3612.
Crossref
Crossref
Leslie C. Norins. (2021) Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease. Antibiotics 10:3, pages 327.
Crossref
Crossref
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Crossref
Germán Plascencia-VillaGeorge Perry. (2021) Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis. Antioxidants & Redox Signaling 34:8, pages 591-610.
Crossref
Crossref
Displaying 200 of 406 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list